Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Long Term Safety and Tolerability Study in Approximately 350 Subjects With Moderate to Severe Chronic, Non-malignant Pain [Phase 3]
This document reports the completion of a Phase 3 long-term safety and tolerability study in approximately 350 adults with moderate to sever…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Sensory Changes From Chest Drains
A completed clinical trial evaluated sensory changes from chest drains in patients after thoracotomy.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee [Phase 3]
A Phase 3 trial evaluating CG5503 Prolonged Release for moderate-to-severe knee osteoarthritis pain has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-12-31Clinical Trial Update: Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic Pain [Phase 3]
Phase 3 trial comparing fentanyl buccal tablets to immediate-release oxycodone for breakthrough pain in chronic pain patients; results were …
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain [Phase 3]
This Phase 3 study evaluated the efficacy and safety of fentanyl buccal tablets versus oxycodone for managing breakthrough pain in chronic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Safety and Efficacy of Intravenous Acetaminophen (IV APAP) in Adult Inpatients [Phase 3]
A Phase 3 trial assessed the safety and efficacy of intravenous acetaminophen (IV APAP) in adult inpatients with acute pain or fever; result…
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Study to Investigate the Safety, Tolerability and Pharmacokinetics of AZD1386 [Phase 1]
This report summarizes the completion of a Phase 1 study evaluating the safety, tolerability and pharmacokinetics of AZD1386 in people with …
-
CLINICAL_TRIALS trial_result · 2010-12-02Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic study of nasally administered esketamine; the trial assessing PK/PD in individuals with pain has…
-
FDA approval · 2010-11-22FDA Approved: TRAMADOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for tramadol hydrochloride, supporting its generic analgesic product.
-
FDA approval · 2010-11-15FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
The FDA approved a supplemental application for OxyContin (oxycodone hydrochloride) submitted by Purdue Pharma LP.
-
FDA approval · 2010-11-01FDA Approved: TAPENTADOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental NDA for tapentadol hydrochloride by Hikma Pharmaceuticals USA Inc., allowing a generic version of tapentadol to …
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: Nicotine Patch as an Analgesic Adjuvant After Surgery [Phase 4]
Phase 4 trial evaluating nicotine patch as an analgesic adjuvant after surgery completed with posted results.
-
CLINICAL_TRIALS research · 2010-10-21Clinical Trial Update: The Effect of Transcranial Direct Current Stimulation for Chronic Pain on Ophthalmologic Parameters [NA]
A clinical trial update examining the effect of transcranial direct current stimulation on chronic pain and its potential impact on ophthalm…
-
CLINICAL_TRIALS research · 2010-10-13Clinical Trial Update: Transcranial Direct Current Stimulation for Chronic Pain Relief [NA]
This document provides a clinical trial update on transcranial direct current stimulation as a potential treatment for chronic pain relief, …
-
FDA approval · 2010-09-24FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Original Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a generic buprenorphine hydrochloride product under an Original Application (ANDA 090622) from PAI Holdings/PAI Pharma. This ma…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee [Phase 3]
A Phase 3 trial of Buprenorphine Transdermal System for moderate-to-severe knee osteoarthritis chronic pain has completed, with results post…
-
FDA approval · 2010-09-01FDA Approved: ADVIL PM- DIPHENHYDRAMINE CITRATE AND IBUPROFEN TABLET, COATED — Supplemental Application (Lil Drug Store Products, Inc)
The FDA approved a supplemental application for Advil PM, a coated tablet containing diphenhydramine citrate and ibuprofen. The sponsor is L…
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Soft Tissue Injuries (TAPED) [Phase 3]
Phase 3 trial of a diclofenac topical patch for acute pain due to mild-to-moderate soft tissue injuries has completed.
-
FDA approval · 2010-08-12FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Naproxen Sodium submitted by Bionpharma Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Matrifen® for Therapy of Severe Chronic Pain®
Nycomed reports the Matrifen trial for severe chronic pain has completed. Results were posted on 2010-08-12.
-
FDA approval · 2010-08-06FDA Approved: ACETAMINOPHEN FOR CHILDREN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Acetaminophen for Children, submitted by Padagis Israel Pharmaceuticals Ltd, indicating an appro…
-
FDA approval · 2010-08-06FDA Approved: ACETAMINOPHEN PAIN RELIEVER FEVER REDUCER — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for Padagis Israel Pharmaceuticals Ltd for Acetaminophen Pain Reliever Fever Reducer, validating its…
-
CLINICAL_TRIALS research · 2010-07-30Clinical Trial Update: Diffuse Noxious Inhibitory Controls (DNIC): Nociceptive Modulation and Interaction With Neurocognitive Performance in Chronic Pain
The update describes a study on diffuse noxious inhibitory controls (DNIC) examining nociceptive modulation and its interaction with neuroco…
-
EMA guidance · 2010-07-23European Medicines Agency concludes review of modified-release oral opioids of the WHO level III scale for the management of pain
The European Medicines Agency concludes its review of modified-release oral opioids used for WHO level III pain management, clarifying safet…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain [Phase 3]
An open-label extension study of extended-release tapentadol (CG5503) in adults with moderate to severe chronic pain completed Phase 3 with …